Review



anti ps6 ribosomal protein s235 236  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc anti ps6 ribosomal protein s235 236
    Anti Ps6 Ribosomal Protein S235 236, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 3711 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+s6+s235+236/Phospho-S6+Ribosomal+Protein+(Ser235%2F236)+Antibody/pm41922778-651-56-61
    Average 96 stars, based on 3711 article reviews
    anti ps6 ribosomal protein s235 236 - by Bioz Stars, 2026-10
    96/100 stars

    Images

    Related Articles

    Lysis:

    Article Title: mTORC1 activity oscillates throughout the cell cycle, promoting mitotic entry and differentially influencing autophagy induction.
    Article Snippet: LC3 puncta intensity per cell was quantified using the Zeiss ZenBlue 3.3 analysis suite. .. Cells were lysed using lysis buffer containing 20 mM Tris pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 50 mM NaF, 1 mM DTT, with protease inhibitor cocktail (Sigma #P8340), phosphatase inhibitor cocktail #2 (Sigma #P5726), and #3 (Sigma #P0044) used at 1:100 each.Western blots were performed using the following antibodies purchased fromCell Signaling Technology and used at 1:1000 dilution unless otherwise indicated: phospho-p70 S6 Kinase T389 (CST #9234 1:2000), p70 S6 Kinase (CST #2708, 1:2500), phospho-4E-BP1 T37/46 (CST #2855), 4E-BP1 (CST #9644, 1:5000), phospho-ULK1 S757 (CST #14202), ULK1 (CST #8054), phospho-S6 S235/236 (CST #4858 1:5000), phospho-S6 S240/244 (CST #5364 1:5000), S6 (CST #2317), Cyclin E1 (CST #20808), Cyclin A2 (CST #4656), Cyclin B1 (CST #4138), Cyclin D2 (CST #3741), Cyclin E2 (CST #4132), phospho-TSC2 T1462 (CST #3617), phospho-GSK3 S9/21 (CST #9331), TSC2 (CST #4308), GAPDH (CST #5174, 1:5000), phospho-Akt T308 (CST #13038), phospho-Akt S473 (CST #4060 1:5000), Akt (CST #4691), phospho-Erk Y202/204 (CST #9106), Erk (CST #9102), phospho-Wee1 S642 (CST #4910), Wee1 (CST #13084), phospho-CDK1 Y15 (CST #4539), CDK1 (CST #9116), phospho-Chk1 S345 (CST #2348), phospho-Chk1 S296 (CST #90178), Chk1 (CST #2360), LC3 A/B (CST #12741). .. Cells were lysed using lysis buffer containing 20 mM Tris pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 50 mM NaF, 1 mM DTT, with protease inhibitor cocktail (Sigma #P8340), phosphatase inhibitor cocktail #2 (Sigma #P5726), and #3 (Sigma #P0044) used at 1:100 each.Western blots were performed using the following antibodies purchased fromCell Signaling Technology and used at 1:1000 dilution unless otherwise indicated: phospho-p70 S6 Kinase T389 (CST #9234 1:2000), p70 S6 Kinase (CST #2708, 1:2500), phospho-4E-BP1 T37/46 (CST #2855), 4E-BP1 (CST #9644, 1:5000), phospho-ULK1 S757 (CST #14202), ULK1 (CST #8054), phospho-S6 S235/236 (CST #4858 1:5000), phospho-S6 S240/244 (CST #5364 1:5000), S6 (CST #2317), Cyclin E1 (CST #20808), Cyclin A2 (CST #4656), Cyclin B1 (CST #4138), Cyclin D2 (CST #3741), Cyclin E2 (CST #4132), phospho-TSC2 T1462 (CST #3617), phospho-GSK3 S9/21 (CST #9331), TSC2 (CST #4308), GAPDH (CST #5174, 1:5000), phospho-Akt T308 (CST #13038), phospho-Akt S473 (CST #4060 1:5000), Akt (CST #4691), phospho-Erk Y202/204 (CST #9106), Erk (CST #9102), phospho-Wee1 S642 (CST #4910), Wee1 (CST #13084), phospho-CDK1 Y15 (CST #4539), CDK1 (CST #9116), phospho-Chk1 S345 (CST #2348), phospho-Chk1 S296 (CST #90178), Chk1 (CST #2360), LC3 A/B (CST #12741).

    Protease Inhibitor:

    Article Title: mTORC1 activity oscillates throughout the cell cycle, promoting mitotic entry and differentially influencing autophagy induction.
    Article Snippet: LC3 puncta intensity per cell was quantified using the Zeiss ZenBlue 3.3 analysis suite. .. Cells were lysed using lysis buffer containing 20 mM Tris pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 50 mM NaF, 1 mM DTT, with protease inhibitor cocktail (Sigma #P8340), phosphatase inhibitor cocktail #2 (Sigma #P5726), and #3 (Sigma #P0044) used at 1:100 each.Western blots were performed using the following antibodies purchased fromCell Signaling Technology and used at 1:1000 dilution unless otherwise indicated: phospho-p70 S6 Kinase T389 (CST #9234 1:2000), p70 S6 Kinase (CST #2708, 1:2500), phospho-4E-BP1 T37/46 (CST #2855), 4E-BP1 (CST #9644, 1:5000), phospho-ULK1 S757 (CST #14202), ULK1 (CST #8054), phospho-S6 S235/236 (CST #4858 1:5000), phospho-S6 S240/244 (CST #5364 1:5000), S6 (CST #2317), Cyclin E1 (CST #20808), Cyclin A2 (CST #4656), Cyclin B1 (CST #4138), Cyclin D2 (CST #3741), Cyclin E2 (CST #4132), phospho-TSC2 T1462 (CST #3617), phospho-GSK3 S9/21 (CST #9331), TSC2 (CST #4308), GAPDH (CST #5174, 1:5000), phospho-Akt T308 (CST #13038), phospho-Akt S473 (CST #4060 1:5000), Akt (CST #4691), phospho-Erk Y202/204 (CST #9106), Erk (CST #9102), phospho-Wee1 S642 (CST #4910), Wee1 (CST #13084), phospho-CDK1 Y15 (CST #4539), CDK1 (CST #9116), phospho-Chk1 S345 (CST #2348), phospho-Chk1 S296 (CST #90178), Chk1 (CST #2360), LC3 A/B (CST #12741). .. Cells were lysed using lysis buffer containing 20 mM Tris pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 50 mM NaF, 1 mM DTT, with protease inhibitor cocktail (Sigma #P8340), phosphatase inhibitor cocktail #2 (Sigma #P5726), and #3 (Sigma #P0044) used at 1:100 each.Western blots were performed using the following antibodies purchased fromCell Signaling Technology and used at 1:1000 dilution unless otherwise indicated: phospho-p70 S6 Kinase T389 (CST #9234 1:2000), p70 S6 Kinase (CST #2708, 1:2500), phospho-4E-BP1 T37/46 (CST #2855), 4E-BP1 (CST #9644, 1:5000), phospho-ULK1 S757 (CST #14202), ULK1 (CST #8054), phospho-S6 S235/236 (CST #4858 1:5000), phospho-S6 S240/244 (CST #5364 1:5000), S6 (CST #2317), Cyclin E1 (CST #20808), Cyclin A2 (CST #4656), Cyclin B1 (CST #4138), Cyclin D2 (CST #3741), Cyclin E2 (CST #4132), phospho-TSC2 T1462 (CST #3617), phospho-GSK3 S9/21 (CST #9331), TSC2 (CST #4308), GAPDH (CST #5174, 1:5000), phospho-Akt T308 (CST #13038), phospho-Akt S473 (CST #4060 1:5000), Akt (CST #4691), phospho-Erk Y202/204 (CST #9106), Erk (CST #9102), phospho-Wee1 S642 (CST #4910), Wee1 (CST #13084), phospho-CDK1 Y15 (CST #4539), CDK1 (CST #9116), phospho-Chk1 S345 (CST #2348), phospho-Chk1 S296 (CST #90178), Chk1 (CST #2360), LC3 A/B (CST #12741).

    other:

    Article Title: mTORC1 activity oscillates throughout the cell cycle, promoting mitotic entry and differentially influencing autophagy induction
    Article Snippet: Phospho-S6 S235/236 , Cell Signaling Technology , Cat #4858; RRID:AB_916156.

    Western Blot:

    Article Title: mTORC1 activity oscillates throughout the cell cycle, promoting mitotic entry and differentially influencing autophagy induction
    Article Snippet: Cells were lysed using lysis buffer containing 20 mM Tris pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 50 mM NaF, 1 mM DTT, with protease inhibitor cocktail (Sigma #P8340), phosphatase inhibitor cocktail #2 (Sigma #P5726), and #3 (Sigma #P0044) used at 1:100 each. .. Western blots were performed using the following antibodies purchased from Cell Signaling Technology and used at 1:1000 dilution unless otherwise indicated: phospho-p70 S6 Kinase T389 (CST #9234 1:2000), p70 S6 Kinase (CST #2708, 1:2500), phospho-4E-BP1 T37/46 (CST #2855), 4E-BP1 (CST #9644, 1:5000), phospho-ULK1 S757 (CST #14202), ULK1 (CST #8054), phospho-S6 S235/236 (CST #4858 1:5000), phospho-S6 S240/244 (CST #5364 1:5000), S6 (CST #2317), Cyclin E1 (CST #20808), Cyclin A2 (CST #4656), Cyclin B1 (CST #4138), Cyclin D2 (CST #3741), Cyclin E2 (CST #4132), phospho-TSC2 T1462 (CST #3617), phospho-GSK3 S9/21 (CST #9331), TSC2 (CST #4308), GAPDH (CST #5174, 1:5000), phospho-Akt T308 (CST #13038), phospho-Akt S473 (CST #4060 1:5000), Akt (CST #4691), phospho-Erk Y202/204 (CST #9106), Erk (CST #9102), phospho-Wee1 S642 (CST #4910), Wee1 (CST #13084), phospho-CDK1 Y15 (CST #4539), CDK1 (CST #9116), phospho-Chk1 S345 (CST #2348), phospho-Chk1 S296 (CST #90178), Chk1 (CST #2360), LC3 A/B (CST #12741). ..



    Similar Products

    96
    Cell Signaling Technology Inc anti ps6 ribosomal protein s235 236
    Anti Ps6 Ribosomal Protein S235 236, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+s6+s235+236/Phospho-S6+Ribosomal+Protein+(Ser235%2F236)+Antibody/pm41922778-651-56-61
    Average 96 stars, based on 1 article reviews
    anti ps6 ribosomal protein s235 236 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc rabbit monoclonal anti s6 s235 236
    Rabbit Monoclonal Anti S6 S235 236, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+s6+s235+236/Phospho-S6+Ribosomal+Protein+(Ser235%2F236)+XP+Rabbit+mAb/pmc12962103-5-0-5
    Average 97 stars, based on 1 article reviews
    rabbit monoclonal anti s6 s235 236 - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc ps6rp s235 236
    Ps6rp S235 236, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+s6+s235+236/Phospho-S6+Ribosomal+Protein+(Ser235%2F236)+XP+Rabbit+mAb/pm41639460-653-94-96
    Average 97 stars, based on 1 article reviews
    ps6rp s235 236 - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc anti phospho s6 ribosomal protein s235 236 rabbit mab
    Anti Phospho S6 Ribosomal Protein S235 236 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+s6+s235+236/bio_rxiv__64898__2026__01__28__701883-435-0-7
    Average 86 stars, based on 1 article reviews
    anti phospho s6 ribosomal protein s235 236 rabbit mab - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc p s6rp s235 236 antibody
    P S6rp S235 236 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+s6+s235+236/Phospho-S6+Ribosomal+Protein+(Ser235%2F236)+Antibody/pmc12947432-103-18-21
    Average 96 stars, based on 1 article reviews
    p s6rp s235 236 antibody - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc phospho s235 236 s6
    Phospho S235 236 S6, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+s6+s235+236/Phospho-S6+Ribosomal+Protein+(Ser235%2F236)+XP+Rabbit+mAb/pmc12910037-72-0-5
    Average 97 stars, based on 1 article reviews
    phospho s235 236 s6 - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc rabbit anti phospho s6 ribosomal protein s235 236
    Rabbit Anti Phospho S6 Ribosomal Protein S235 236, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+s6+s235+236/Phospho-S6+Ribosomal+Protein+(Ser235%2F236)+XP+Rabbit+mAb/pmc12774701-4-0-6
    Average 97 stars, based on 1 article reviews
    rabbit anti phospho s6 ribosomal protein s235 236 - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc p s6 s235 236
    a ) Chemical structure of L-serine and L-2A5HPA. Representative volcano plot of untargeted analysis comparing SK-GT-4 ( b ) and OA-P4C cells ( c ) treated with or without L-2A5HPA (50 µM). The grey circles represent metabolites detected, and L-2A5HPA is highlighted in red. Intracellular levels of L-serine and L-2A5HPA are shown in SK-GT-4 cells ( d ) and OA-P4C cells ( e ). f ) Correlation between the plasma levels of serine and L-2A5HPA (n=11). The Pearson r value and P value are shown. g ) Representative image of SW982 cells that were nutrient-deprived in the absence or presence of L-2A5HPA (0, 50, 200 and 2,000 µM) for 4 days, recovered in complete media for 8 days and stained with sulforhodamine B. h ) Quantification of sulforhodamine B absorbance at 510 nm. i ) Immunoblot analysis of U2OS cells nutrient-deprived in the presence or absence of L-2A5HPA for 5 days. mTORC1 activation was measured by the levels of phosphor-S6 <t>(S235-236).</t> Total S6 is shown as a loading control. j ) Representative images from U2OS cells starved and treated with vehicle, L-Serine (2mM) or L-2A5HPA (2mM) for 5 days. k ) Representative images from cells treated as in j ), then exposed to complete media for 5 days and stained with sulforhodamine B. l ) Quantification of sulforhodamine B absorbance at 510 nm from three biological replicates. m ) Representative images of starved cells treated with either L-2A5HPA (2mM) or D-2A5HPA (2mM) for 5 days. n ) Representative images from cells stained with sulforhodamine B after being treated as in m ), then exposed to complete media for 5 days. o ) Quantification of sulforhodamine B absorbance at 510 nm of three biological replicates. p ) Relative intracellular levels of L-2A5HPA or D-2A5HPA in U2OS cells after being exposed to 50 µM of each of the enantiomers for 1 min. Bars represent the average ± SEM of three independent replicates. Data were analyzed using a one-way ANOVA, Student’s t-test or One-sample t-test (p). Circles represent metabolites, independent experiments or individual patients.
    P S6 S235 236, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+s6+s235+236/Phospho-S6+Ribosomal+Protein+(Ser235%2F236)+XP+Rabbit+mAb/bio_rxiv__64898__2026__01__15__699640-204-31-33
    Average 97 stars, based on 1 article reviews
    p s6 s235 236 - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    Image Search Results


    a ) Chemical structure of L-serine and L-2A5HPA. Representative volcano plot of untargeted analysis comparing SK-GT-4 ( b ) and OA-P4C cells ( c ) treated with or without L-2A5HPA (50 µM). The grey circles represent metabolites detected, and L-2A5HPA is highlighted in red. Intracellular levels of L-serine and L-2A5HPA are shown in SK-GT-4 cells ( d ) and OA-P4C cells ( e ). f ) Correlation between the plasma levels of serine and L-2A5HPA (n=11). The Pearson r value and P value are shown. g ) Representative image of SW982 cells that were nutrient-deprived in the absence or presence of L-2A5HPA (0, 50, 200 and 2,000 µM) for 4 days, recovered in complete media for 8 days and stained with sulforhodamine B. h ) Quantification of sulforhodamine B absorbance at 510 nm. i ) Immunoblot analysis of U2OS cells nutrient-deprived in the presence or absence of L-2A5HPA for 5 days. mTORC1 activation was measured by the levels of phosphor-S6 (S235-236). Total S6 is shown as a loading control. j ) Representative images from U2OS cells starved and treated with vehicle, L-Serine (2mM) or L-2A5HPA (2mM) for 5 days. k ) Representative images from cells treated as in j ), then exposed to complete media for 5 days and stained with sulforhodamine B. l ) Quantification of sulforhodamine B absorbance at 510 nm from three biological replicates. m ) Representative images of starved cells treated with either L-2A5HPA (2mM) or D-2A5HPA (2mM) for 5 days. n ) Representative images from cells stained with sulforhodamine B after being treated as in m ), then exposed to complete media for 5 days. o ) Quantification of sulforhodamine B absorbance at 510 nm of three biological replicates. p ) Relative intracellular levels of L-2A5HPA or D-2A5HPA in U2OS cells after being exposed to 50 µM of each of the enantiomers for 1 min. Bars represent the average ± SEM of three independent replicates. Data were analyzed using a one-way ANOVA, Student’s t-test or One-sample t-test (p). Circles represent metabolites, independent experiments or individual patients.

    Journal: bioRxiv

    Article Title: L-pentahomoserine correlates with therapy outcome in esophageal cancer and promotes metabolic adaptations that support cell survival under nutrient-deprived conditions

    doi: 10.64898/2026.01.15.699640

    Figure Lengend Snippet: a ) Chemical structure of L-serine and L-2A5HPA. Representative volcano plot of untargeted analysis comparing SK-GT-4 ( b ) and OA-P4C cells ( c ) treated with or without L-2A5HPA (50 µM). The grey circles represent metabolites detected, and L-2A5HPA is highlighted in red. Intracellular levels of L-serine and L-2A5HPA are shown in SK-GT-4 cells ( d ) and OA-P4C cells ( e ). f ) Correlation between the plasma levels of serine and L-2A5HPA (n=11). The Pearson r value and P value are shown. g ) Representative image of SW982 cells that were nutrient-deprived in the absence or presence of L-2A5HPA (0, 50, 200 and 2,000 µM) for 4 days, recovered in complete media for 8 days and stained with sulforhodamine B. h ) Quantification of sulforhodamine B absorbance at 510 nm. i ) Immunoblot analysis of U2OS cells nutrient-deprived in the presence or absence of L-2A5HPA for 5 days. mTORC1 activation was measured by the levels of phosphor-S6 (S235-236). Total S6 is shown as a loading control. j ) Representative images from U2OS cells starved and treated with vehicle, L-Serine (2mM) or L-2A5HPA (2mM) for 5 days. k ) Representative images from cells treated as in j ), then exposed to complete media for 5 days and stained with sulforhodamine B. l ) Quantification of sulforhodamine B absorbance at 510 nm from three biological replicates. m ) Representative images of starved cells treated with either L-2A5HPA (2mM) or D-2A5HPA (2mM) for 5 days. n ) Representative images from cells stained with sulforhodamine B after being treated as in m ), then exposed to complete media for 5 days. o ) Quantification of sulforhodamine B absorbance at 510 nm of three biological replicates. p ) Relative intracellular levels of L-2A5HPA or D-2A5HPA in U2OS cells after being exposed to 50 µM of each of the enantiomers for 1 min. Bars represent the average ± SEM of three independent replicates. Data were analyzed using a one-way ANOVA, Student’s t-test or One-sample t-test (p). Circles represent metabolites, independent experiments or individual patients.

    Article Snippet: The primary antibodies used: Cleaved Caspase 3 (Cell Signaling, 9662 dilution 1:500), Cleaved PARP (Cell Signaling, 9532 dilution 1:1000), P62 (Cell Signaling, 397495 dilution 1:1000), LC3BII (Cell Signaling, 3868 dilution 1:1000), P-S6 S235/236 (Cell Signaling 4858 dilution 1:1000), S6 (Cell Signaling, 2317 dilution 1:1000), β-actin (Cell Signaling 4970S dilution 1:1000), Vinculin (Merck, MAB3574 dilution 1:1000), PCB (ab126707 dilution 1:1000).

    Techniques: Clinical Proteomics, Staining, Western Blot, Activation Assay, Control